SAN
CARLOS, Calif., Oct. 28,
2024 /PRNewswire/ -- Sonder Capital, a leading
healthcare venture firm focused on innovative technologies ushering
in a new standard of care in medicine, announced the addition of
Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and
co-founder of MedtechWomen, as a Venture Partner.
Kilpatrick earned her Ph.D. from Georgia
Tech in mechanical engineering with a focus in
bioengineering and a minor in applied mathematics. Most recently,
she was the CEO and Executive Chair of the Board at Evidation
Health, a technology company that pioneered the use of
person-generated health data and connected devices in
decentralized research and large-scale health
programs. Prior to Evidation, Kilpatrick held leadership roles in
medical device and molecular diagnostic companies, including
multiple roles at Guidant Corporation such as Research Fellow,
Director of Research and Technology Development, and Director of
New Ventures, prior to its acquisition by Boston Scientific. She is
the co-Founder of MedtechWomen and the MedtechVision Conference,
held annually in Silicon Valley and currently serves on the Board
of Directors at Sleep Number (NASDAQ:SNBR), NextGen Jane, and
Sutter Health, one of the largest and most innovative healthcare
systems in the US providing care to millions throughout
California.
Kilpatrick's background in medical devices coupled with her
expertise in digital health technology will strengthen the Sonder
team's ability to navigate and identify future investments in the
medtech sector as it rapidly evolves to integrate multi-modal
health data and AI.
"I'm excited to join the Sonder team and be a part of creating
what's next in medtech," said Kilpatrick. "There is no doubt that
the sector has driven better patient outcomes for decades. But I
believe medtech is entering a new era where novel technologies will
drive entirely new standards of care and transform both the
clinician and patient experience in ways we are just beginning to
imagine."
"We couldn't be more excited to welcome Deb to the Sonder team,"
said Kate Garrett, Managing Partner
of Sonder Capital. "The future of the medtech industry will
become a convergence of big data, AI and connected devices,
creating unprecedented opportunities to improve healthcare. With a
career deeply rooted in all of these areas, Deb brings unparalleled
expertise to our team. Beyond that, Deb has been a champion of
women leaders in the healthcare sector her entire career, something
I and thousands of others have benefitted from. We are thrilled to
be working side by side with her."
About Sonder Capital
Sonder's team of veteran investors, innovators,
founder-operators, and company builders is known not only for their
individual achievements, but also for their collective success in
creating, funding, and leading private and public companies that
have transformed healthcare for millions of patients globally —
including Intuitive Surgical (NASDAQ:ISRG), Shockwave Medical
(NASDAQ:SWAV), Procept Biorobotics (NASDAQ:PRCT), Auris Health, and
Reflexion Medical, among others. Sonder's extensive network of
limited partners is global and includes industry leaders,
high-net-worth individuals, and leading family offices focused on
investing in game-changing healthcare technologies. Sonder Capital
was co-founded in 2019 by healthcare luminaries Jay Watkins and Fred
Moll, M.D
Contacts
Marisa Meehan,
Sonder Capital
marisa@sondercapital.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/deborah-kilpatrick-joins-sonder-capital-as-its-newest-venture-partner-302288301.html
SOURCE Sonder Capital